← All organizations
Highest phase reached
Phase 4
First clinical trial
Apr 1, 2017Last known activity
May 4, 2020
Timeline
No events for the selected filters.
Drugs by trial phase (5 distinct, 3 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (2 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (9)
- NCT04377646Lead sponsorPhase 3May 4, 2020
- NCT04377646Study chairPhase 3May 4, 2020
- NCT04377646Study directorPhase 3May 4, 2020
- NCT03434691Study directorN/AFeb 8, 2018
- NCT03434691Reponsible party - principal investigatorN/AFeb 8, 2018
- NCT03434691Lead sponsorN/AFeb 8, 2018
- NCT04376970Reponsible party - principal investigatorPhase 4Apr 1, 2017
- NCT04376970Lead sponsorPhase 4Apr 1, 2017
- NCT04376970Study directorPhase 4Apr 1, 2017
Details
- Last known activity
- May 4, 2020